Indolent enhancing spinal lesions mimicking spinal metastasis in pediatric patients with malignant primary brain

Hsin-Wei Wu1,2, Shih-Chieh Lin2,3, Ching-Lan Wu1,2

  • 1Department of Radiology, Taipei Veterans General Hospital, 201 Sec. 2, Shih-Pai Rd., Taipei, 11217, Taiwan.

Scientific Reports
|February 3, 2022
PubMed

Insights

Spinal metastasis from pediatric primary brain tumors is rare. Indolent enhancing spinal lesions (IESLs) can mimic metastasis on MRI, but distinct imaging features allow differentiation, suggesting follow-up over aggressive treatment.

Area of Science:

  • Pediatric Radiology
  • Oncology Imaging
  • Spinal Imaging

Background:

  • Spinal metastasis from malignant primary brain tumors (MPBTs) in pediatric patients is uncommon.
  • Indolent enhancing spinal lesions (IESLs) from prior treatment can be misdiagnosed as metastasis on MRI.
  • Misdiagnosis can lead to unnecessary investigations and treatments in pediatric patients.

Purpose of the Study:

  • To differentiate IESLs from spinal metastasis in pediatric patients with MPBTs using imaging characteristics.
  • To evaluate the utility of MRI, CT, and bone scan findings in distinguishing these conditions.

Main Methods:

  • Retrospective analysis of 12 pediatric patients diagnosed with spinal lesions between 2005-2020.
  • Patients included those with MPBT and IESL (n=3) and malignant tumors with metastases (n=9).
  • Evaluation of imaging findings including lesion shape, enhancement pattern, vertebral body changes, and venous involvement.

Main Results:

  • IESLs were round/ovoid and showed target-shaped enhancement, unlike irregular metastases.
  • Metastases frequently presented with vertebral body pathologic fracture, expansile shape, and basivertebral vein obliteration.
  • Osteoblastic changes on CT were more common in IESLs (100%) compared to metastases (22.2%).

Conclusions:

  • Distinct imaging characteristics of IESLs in pediatric patients with MPBTs can differentiate them from spinal metastases.
  • These findings support close follow-up for suspected IESLs instead of aggressive diagnostic and therapeutic interventions.
  • Accurate differentiation is crucial to avoid overtreatment and manage pediatric patients effectively.

Related Concept Videos